Dr Sharman's blog cll-nhl.com, is well worth keeping an eye on for pertinent but easily understandable articles on lymphomas, with CLL getting plenty of attention lately.
In the video below, Andrew Schorr of Patient Power, asks Dr Sharman to discuss whether emerging therapies will replace FCR.
Some quotes from the interview:
"We're in really a phenomenally exciting time for Chronic Lymphocytic Leukaemia. I think we're quickly transitioning from an era of chemotherapy to an era of targeted therapy."
"FCR was a wonderful regimen for its day. I think that day is passing."